Related Experiment Video

Updated: Apr 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Improving medication adherence in hypercholesterolemia: challenges and solutions

Justin Gatwood1, James E Bailey2

  • 1University of Tennessee Health Science Center, College of Pharmacy, Center for Health System Improvement, Memphis, TN, USA.

Vascular Health and Risk Management
|November 15, 2014
PubMed

Insights

Medication nonadherence is a major problem for patients with high cholesterol, leading to poor health outcomes. Understanding reasons for nonadherence and implementing new strategies can improve medication adherence in hypercholesterolemia management.

Area of Science:

  • Public Health
  • Cardiology
  • Pharmacology

Background:

  • Medication nonadherence is a significant public health concern with substantial economic and health consequences.
  • Hypercholesterolemia affects millions, increasing risks for cardiovascular and cerebrovascular events.
  • Despite advances in high cholesterol treatment, poor adherence remains a barrier to optimal patient outcomes.

Purpose of the Study:

  • To provide an overview of the reasons for medication nonadherence in patients with hypercholesterolemia.
  • To describe recent initiatives aimed at reducing nonadherence in this population.
  • To offer suggested approaches for enhancing medication adherence among patients with high cholesterol.

Main Methods:

  • Literature review on medication nonadherence in hypercholesterolemia.
  • Analysis of current strategies to improve adherence.
  • Synthesis of practical recommendations for stakeholders.

Main Results:

  • Identified key factors contributing to medication nonadherence in hypercholesterolemia.
  • Highlighted recent advancements and ongoing efforts to address nonadherence.
  • Outlined evidence-based strategies for improving medication taking.

Conclusions:

  • Addressing medication nonadherence is critical for improving health outcomes in hypercholesterolemia.
  • A multi-faceted approach involving practitioners, patients, and payers is necessary.
  • Further research and implementation of interventions are needed to optimize cholesterol management.

Keywords:
cardiovascular diseaselipid managementmedication use

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.6K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
650
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
461
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
601
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
956